Proteoimic analysis of all-trans-retinoic acid treated acute promyelocytic leukemia cells using mass spectrometry and amino acid specific stable isotope labeling

Keyphrases

• Mass Spectrometry 100%
• Amino Acids 100%
• All-trans Retinoic Acid 100%
• Acid Treatment 100%
• Stable Isotope Labeling 100%
• Acute Promyelocytic Leukemia Cells 100%
• Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS) 66%
• Matrix-assisted Laser Desorption Ionization-time of Flight Mass Spectrometry (MALDI-TOF MS) 66%
• Cell Proliferation 33%
• Clinical Significance 33%
• Apoptosis 33%
• Mass Spectrometry Analysis 33%
• Tumor Suppression 33%
• Unknown Function 33%
• Leukemia Cell Lines 33%
• Molecular Markers 33%
• Proteomic Analysis 33%
• Protein Identification 33%
• Tagging Method 33%
• Differentially Expressed Proteins 33%
• Protein Prospector 33%

Biochemistry, Genetics and Molecular Biology

• Mass Spectrometry 100%
• Amino Acid 100%
• Matrix-Assisted Laser Desorption/Ionization 100%
• Tandem Mass Spectrometry 100%
• Tretinoin 100%
• Time-of-Flight Mass Spectrometry 100%
• Isotope Labeling 100%
• Cell Proliferation 50%
• Programmed Cell Death 50%
• Cell Cycle 50%
• Protein Expression 50%
• Proteomics 50%
• Genetic Marker 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Amino Acid 100%
• Retinoic Acid 100%
• Promyelocytic Leukemia 100%
• Stable Isotope 100%
• Matrix-Assisted Laser Desorption/Ionization 66%
• Cancer Inhibition 33%
• Molecular Marker 33%